Re: Status of the project?

Michael Heuer <[email protected]> Sun, 11 Jul 2021 19:23:05 -0500
Newsgroups gmane.comp.java.bio.general
Message-ID <[email protected]>
--===============8352422420251370351==
Content-Type: multipart/alternative;
	boundary="Apple-Mail=_639B98B7-F790-4F15-8C73-0E6267EE4235"


--Apple-Mail=_639B98B7-F790-4F15-8C73-0E6267EE4235
Content-Transfer-Encoding: quoted-printable
Content-Type: text/plain;
	charset=us-ascii

Hello Richard,

Welcome and thank you for your contributions!

Speaking for the BioJava 1.x series, yes, that is in maintenance mode =
now.

https://github.com/biojava/biojava-legacy =
<https://github.com/biojava/biojava-legacy>

We'll keep cutting new 1.9.x point releases for security fixes and =
dependency updates as necessary.

BioJava proper (5.4.0+) keeps plugging along; I'll let someone else =
chime in on that.

Cheers,

   michael


> On Jul 11, 2021, at 7:13 PM, Richard Adams <[email protected]> wrote:
>=20
> Hi
>  I've just joined the mailing list so wanted to say hello. I used to =
work in bioinformatics/systems biology but for the last few years have =
been  doing full time Java development in research data management / =
ELNs.=20
>=20
> I've  started looking at BioJava to incorporate it into some of our =
projects, noticed that test coverage is missing in a few places so have =
submitted some PRs to start tackling this - and I hope to be able to =
contribute more over time as it's a good way to explore the code-base.
>=20
>  In general, what is the state of the project, is it in 'maintenance' =
mode now? I notice a lot of roadmap issues for version 6 are several =
years old and the mailing list seems quite quiet this year.
>=20
> Cheers
>  Richard Adams
> _______________________________________________
> Biojava-l mailing list  -  [email protected]
> https://mailman.open-bio.org/mailman/listinfo/biojava-l


--Apple-Mail=_639B98B7-F790-4F15-8C73-0E6267EE4235
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html;
	charset=us-ascii

<html><head><meta http-equiv=3D"Content-Type" content=3D"text/html; =
charset=3Dus-ascii"></head><body style=3D"word-wrap: break-word; =
-webkit-nbsp-mode: space; line-break: after-white-space;" class=3D"">Hello=
 Richard,<div class=3D""><br class=3D""></div><div class=3D"">Welcome =
and thank you for your contributions!</div><div class=3D""><br =
class=3D""></div><div class=3D"">Speaking for the BioJava 1.x series, =
yes, that is in maintenance mode now.</div><div class=3D""><br =
class=3D""></div><div class=3D""><a =
href=3D"https://github.com/biojava/biojava-legacy" =
class=3D"">https://github.com/biojava/biojava-legacy</a></div><div =
class=3D""><br class=3D""></div><div class=3D"">We'll keep cutting new =
1.9.x point releases for security fixes and dependency updates as =
necessary.</div><div class=3D""><br class=3D""></div><div =
class=3D"">BioJava proper (5.4.0+) keeps plugging along; I'll let =
someone else chime in on that.</div><div class=3D""><br =
class=3D""></div><div class=3D"">Cheers,</div><div class=3D""><br =
class=3D""></div><div class=3D"">&nbsp; &nbsp;michael</div><div =
class=3D""><br class=3D""><div><br class=3D""><blockquote type=3D"cite" =
class=3D""><div class=3D"">On Jul 11, 2021, at 7:13 PM, Richard Adams =
&lt;<a href=3D"mailto:[email protected]" =
class=3D"">[email protected]</a>&gt; wrote:</div><br =
class=3D"Apple-interchange-newline"><div class=3D""><div dir=3D"ltr" =
class=3D""><div class=3D"">Hi</div><div class=3D"">&nbsp;I've just =
joined the mailing list so wanted to say hello. I used to work in =
bioinformatics/systems biology but for the last few years have =
been&nbsp; doing full time Java development in research data management =
/ ELNs. <br class=3D""></div><div class=3D""><br class=3D""></div><div =
class=3D"">I've&nbsp; started looking at BioJava to incorporate it into =
some of our projects, noticed that test coverage is missing in a few =
places so have submitted some PRs to start tackling this - and I hope to =
be able to contribute more over time as it's a good way to explore the =
code-base.</div><div class=3D""><br class=3D""></div><div =
class=3D"">&nbsp;In general, what is the state of the project, is it in =
'maintenance' mode now? I notice a lot of roadmap issues for version 6 =
are several years old and the mailing list seems quite quiet this =
year.</div><div class=3D""><br class=3D""></div><div =
class=3D"">Cheers</div><div class=3D"">&nbsp;Richard Adams<br =
class=3D""></div></div>
_______________________________________________<br class=3D"">Biojava-l =
mailing list &nbsp;- &nbsp;<a href=3D"mailto:[email protected]" =
class=3D"">[email protected]</a><br class=3D""><a =
href=3D"https://mailman.open-bio.org/mailman/listinfo/biojava-l" =
class=3D"">https://mailman.open-bio.org/mailman/listinfo/biojava-l</a><br =
class=3D""></div></blockquote></div><br class=3D""></div></body></html>=

--Apple-Mail=_639B98B7-F790-4F15-8C73-0E6267EE4235--

--===============8352422420251370351==
Content-Type: text/plain; charset="us-ascii"
MIME-Version: 1.0
Content-Transfer-Encoding: 7bit
Content-Disposition: inline

_______________________________________________
Biojava-l mailing list  -  [email protected]
https://mailman.open-bio.org/mailman/listinfo/biojava-l

--===============8352422420251370351==--